Paper · 307026
Partial purification and molecular characterization of a lymphokine (costimulator) required for the mitogenic response of mouse thymocytes in vitro.
Shaw J and 2 others. J Immunol, 1978. Cited by 131 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Partial purification and molecular characterization of a lymphokine (costimulator) required for the mitogenic response of mouse thymocytes in vitro. Papers, record 307026. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/307026
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Partial purification and molecular characterization of a lymphokine (costimulator) required for the mitogenic response of mouse thymocytes in vitro.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Concanavalin A | Major topic |
| Lymphocyte Activation | Major topic |
| Lymphokines | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Chemical Phenomena | |
| Chemistry, Physical | |
| Chromatography, Gel | |
| Hot Temperature | |
| Isoelectric Focusing | |
| Mice | |
| Mice, Inbred CBA | |
| Spleen | |
| Trypsin |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,172,665 | Advances in the Xenopus immunome: Diversification, expansion, and contraction. | Dev Comp Immunol | 2023 | https://conductscience.org/library/papers/37172665 | PubMed |
| 29,443,657 | IL-2 and Beyond in Cancer Immunotherapy. | J Interferon Cytokine Res | 2018 | https://conductscience.org/library/papers/29443657 | PubMed |
| 23,230,441 | Toward a molecular understanding of adaptive immunity: a chronology - part II. | Front Immunol | 2012 | https://conductscience.org/library/papers/23230441 | PubMed |
| 8,729,953 | A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinoma. | Invest New Drugs | 1995 | https://conductscience.org/library/papers/8729953 | PubMed |
| 7,007,219 | Purification and properties of a factor from leukaemic T cells which non-specifically enhances the antibody response. | Immunology | 1981 | https://conductscience.org/library/papers/7007219 | PubMed |
| 6,979,751 | Purification and initial characterization of rat interleukin 2. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6979751 | PubMed |
| 6,978,843 | Concanavalin A stimulation of mouse lymphocytes at low concentration. II. The effect of conditioned medium from peritoneal exudate cells and from lymphocyte cultures. | Immunology | 1982 | https://conductscience.org/library/papers/6978843 | PubMed |
| 6,976,411 | A specific biosynthetic marker for immature thymic lymphoblasts. Active synthesis of thymus-leukemia antigen restricted to proliferating cells. | J Exp Med | 1982 | https://conductscience.org/library/papers/6976411 | PubMed |
| 6,972,903 | Studies on T-lymphocyte activation. I. Is competence inductions in thymocytes by phorbol myristate acetate, an accessory cell-independent event? | Immunology | 1981 | https://conductscience.org/library/papers/6972903 | PubMed |
| 6,969,778 | In vitro analysis of allogeneic lymphocyte interaction. V. Identification and characterization of two components of allogeneic effect factor, one of which displays H-2-restricted helper activity and the other, T cell-growth factor activity. | J Exp Med | 1981 | https://conductscience.org/library/papers/6969778 | PubMed |
1 to 10 of 19
See all 19 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/307026
GET https://conductscience.org/api/papers/v1/307026/authors